Literature DB >> 15373942

Intranasal and inhaled corticosteroids in allergic rhinitis and asthma.

Daniel K C Lee, Brian J Lipworth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15373942      PMCID： PMC1884600          DOI： 10.1111/j.1365-2125.2004.02173.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients.

Authors:  G J Braunstahl; A Kleinjan; S E Overbeek; J B Prins; H C Hoogsteden; W J Fokkens
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

Review 2.  Upper airway disorders and asthma: a syndrome of airway inflammation.

Authors:  Ricardo Z Vinuya
Journal:  Ann Allergy Asthma Immunol       Date:  2002-04       Impact factor: 6.347

3.  Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness.

Authors:  W T Watson; A B Becker; F E Simons
Journal:  J Allergy Clin Immunol       Date:  1993-01       Impact factor: 10.793
  3 in total
  1 in total

1.  Azelastine potentiates antiasthmatic dexamethasone effect on a murine asthma model.

Authors:  Carlos D Zappia; Ariadna Soto; Gina Granja-Galeano; Ignacio Fenoy; Natalia Fernandez; Carlos A Davio; Carina Shayo; Carlos P Fitzsimons; Alejandra Goldman; Federico Monczor
Journal:  Pharmacol Res Perspect       Date:  2019-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.